AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
INSULIN ISOPHANE
7 registrations across 3 African markets— 5 active
Markets with INSULIN ISOPHANE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| INSULIDD N INJECTABLE; INJECTION | 🇿🇼Zimbabwe | M. J. BIOPHARMA (PVT) LTD | active | Dec 2027 |
| INSUGEN-N 100IU/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2024 |
| BIOSULIN_N 100IU/ML SUSPENSION FOR INJECTION SUSPENSION FOR INJECTION | 🇲🇼Malawi | — | expired | Mar 2024 |
| INSULIN ISOPHANE PARENTERAL
ORDINARY S C VIALS | 🇺🇬Uganda | M.J BIOPHARM PVT LTD | active | — |
| INSULIN ISOPHANE PARENTERAL
ORDINARY S C VIALS | 🇺🇬Uganda | M.J BIOPHARM PVT LTD | active | — |
| INSULIN ISOPHANE PARENTERAL
ORDINARY S C
VIALS | 🇺🇬Uganda | M.J BIOPHARM PVT LTD | active | — |
| INSULIN ISOPHANE PARENTERAL
ORDINARY S C
VIALS | 🇺🇬Uganda | M.J BIOPHARM PVT LTD | active | — |
INSULIN ISOPHANE in Africa — Regulatory Overview
INSULIN ISOPHANE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.